Successful exit: adivo joins Zoetis
adivo’s team and platform will strengthen Zoetis’ capabilities in therapeutic antibody drug discovery for companion animals
19-Sep-2023 -
adivo GmbH, a leader in discovering species-specific therapeutic antibodies for pets, announced that it is part of Zoetis, the world’s leading animal health company. HTGF and the existing investors OCCIDENT and MorphoSys AG sold their shares as part of the deal. HTGF was one of the first ...
animal health
antibodies
antibody drugs
+1